Abstract
In recent years, the use of adaptive designs in clinical trials has attracted much attention and been widely discussed within the pharmaceutical/biotechnology industry, regulatory agencies such as ...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have